How to Perform a Coagulase Test: Slide and Tube Methods

The coagulase test is a fundamental microbiological procedure used to differentiate Staphylococcus aureus (coagulase-positive) from other staphylococcal species (coagulase-negative staphylococci, or CoNS) by detecting the presence of the enzyme coagulase. This test is essential in clinical and research settings for identifying pathogenic S. aureus from mixed bacterial populations, as coagulase production is a key virulence marker. The slide method detects bound coagulase (clumping factor) on the bacterial cell surface, while the tube method detects free coagulase secreted into the medium. Both methods are routinely performed at Biosafety Level 1 (BSL-1) using pure cultures of staphylococci, and they are most useful when screening for S. aureus in samples from skin, wounds, or food products, or when confirming the identity of isolates in teaching laboratories.

At a Glance

Scientific Principle

Coagulase is an enzyme produced by Staphylococcus aureus that converts fibrinogen to fibrin, causing plasma to clot. This property is a key virulence factor because it allows the bacterium to evade host immune defenses by forming a protective fibrin layer around itself. The coagulase test exploits this enzymatic activity using rabbit plasma as the substrate.

Bound coagulase (clumping factor) is an enzyme attached to the bacterial cell wall that directly reacts with fibrinogen in plasma, causing the bacterial cells to clump together. This reaction occurs rapidly (within seconds) and is the basis of the slide coagulase test. The slide method is a quick screening tool but can yield false positives with certain staphylococcal strains that autoagglutinate or produce protein A.

Free coagulase is an extracellular enzyme secreted by S. aureus that reacts with a plasma factor (coagulase-reacting factor, a form of prothrombin) to form a complex called staphylothrombin. This complex then converts fibrinogen to fibrin, forming a visible clot in the tube. The tube coagulase test is more specific and is considered the gold standard for confirming S. aureus identification.

The distinction between coagulase-positive and coagulase-negative staphylococci is clinically significant. S. aureus is a major human pathogen responsible for a wide range of infections, from skin abscesses to life-threatening conditions like endocarditis and sepsis. In contrast, CoNS such as Staphylococcus epidermidis, Staphylococcus haemolyticus, and Staphylococcus capitis are typically commensal organisms but can cause opportunistic infections, particularly in immunocompromised patients or those with indwelling medical devices [1]. The coagulase test is therefore a critical first step in differentiating these groups.

Materials and Instrumentation Choices

Bacterial Culture Requirements

• Pure culture: Use an 18–24 hour culture grown on non-selective agar (e.g., tryptic soy agar, blood agar, or nutrient agar). Older cultures may lose coagulase activity, leading to false-negative results.
• Colony morphology: Select well-isolated, typical colonies. For S. aureus, these are usually golden-yellow, beta-hemolytic (on blood agar), and 1–3 mm in diameter. However, colony color and hemolysis are not definitive for identification.

Plasma Selection

• Rabbit plasma: This is the standard substrate for both slide and tube coagulase tests. Rabbit plasma is preferred because it lacks inhibitors that may interfere with the reaction and provides consistent results. Human plasma can be used but is less reliable due to variable levels of coagulase-reacting factor and potential inhibitors.
• Plasma preparation: For the slide test, undiluted or slightly diluted plasma (1:1 with saline) is used. For the tube test, plasma is typically diluted 1:5 or 1:10 in sterile saline or broth to provide sufficient substrate for the free coagulase reaction.
• Commercial kits: Many laboratories use commercially available coagulase plasma kits that include lyophilized rabbit plasma with standardized reactivity. These kits often include positive and negative controls.

Additional Materials

• Glass slides: Clean, grease-free slides are essential for the slide test. Use a new slide for each test to avoid cross-contamination.
• Sterile loop or inoculating needle: For transferring bacterial colonies.
• Sterile test tubes: 13 × 100 mm or similar size for the tube test.
• Saline solution: 0.85% sterile saline for diluting plasma and suspending bacteria.
• Incubator: Set to 35–37°C for the tube test.
• Timer or clock: For monitoring reaction times.

Quality Control Strains

• Positive control: Staphylococcus aureus ATCC 25923 (or a known coagulase-positive strain).
• Negative control: Staphylococcus epidermidis ATCC 12228 (or a known coagulase-negative strain).
• Autoagglutination control: A suspension of the test organism in saline (without plasma) to check for spontaneous clumping.

Controls

Proper controls are essential for valid coagulase test results. Without controls, false positives or false negatives can lead to misidentification.

Positive Control

• Purpose: Confirms that the plasma is reactive and the test system is working.
• Procedure: Test a known coagulase-positive S. aureus strain (e.g., ATCC 25923) in parallel with the unknown isolate.
• Expected result: Clumping within 10–15 seconds (slide test) or clot formation within 4 hours (tube test).

Negative Control

• Purpose: Confirms that the plasma does not clot spontaneously and that the test system does not produce false positives.
• Procedure: Test a known coagulase-negative strain (e.g., S. epidermidis ATCC 12228) in parallel.
• Expected result: No clumping (slide test) or no clot formation (tube test) after 24 hours.

Autoagglutination Control

• Purpose: Detects strains that clump spontaneously in saline, which can mimic a positive slide coagulase test.
• Procedure: Mix a loopful of the test organism with a drop of sterile saline on a slide. Observe for clumping.
• Expected result: No clumping. If clumping occurs, the slide test is invalid, and the tube test must be used.

Plasma Control

• Purpose: Ensures the plasma itself is not contaminated or degraded.
• Procedure: Incubate a tube containing only diluted plasma (no bacteria) alongside the test.
• Expected result: No clot formation after 24 hours.

Conceptual Workflow

Slide Coagulase Test (Bound Coagulase)

1. Prepare the slide: Place two drops of sterile saline on a clean glass slide, approximately 2–3 cm apart.
2. Emulsify the bacteria: Using a sterile loop, pick a small portion of a well-isolated colony (18–24 hours old) and emulsify it in each drop of saline to create a smooth, milky suspension. Avoid clumps.
3. Add plasma: Add one drop of rabbit plasma to one of the bacterial suspensions. Mix gently with the loop. The other suspension serves as the autoagglutination control.
4. Observe for clumping: Rock the slide gently back and forth for up to 20 seconds. Look for visible clumping or aggregation of bacterial cells.
5. Interpretation:
   • Positive: Visible clumping within 10–15 seconds (granular appearance).
   • Negative: No clumping; the suspension remains homogeneous.
   • Invalid: Clumping in the saline control (autoagglutination) – proceed to tube test.

Tube Coagulase Test (Free Coagulase)

1. Prepare plasma dilution: Dilute rabbit plasma 1:5 or 1:10 in sterile saline or tryptic soy broth. For example, add 0.2 mL plasma to 0.8 mL diluent.
2. Inoculate the tube: Using a sterile loop, pick 3–4 well-isolated colonies from an 18–24 hour culture and emulsify them in the diluted plasma. Alternatively, add 0.1 mL of a bacterial suspension (0.5 McFarland standard) to the plasma.
3. Incubate: Place the tube in a 35–37°C incubator. Examine at 1, 2, 4, and 24 hours.
4. Observe for clot formation: Gently tilt the tube to check for a clot. Do not shake vigorously, as this can disrupt a weak clot.
5. Interpretation:
   • Positive: Any visible clot (from a loose gelatinous clot to a solid clot that does not move when the tube is tilted).
   • Negative: No clot; the plasma remains liquid.
   • Weak positive: A small, loose clot that may be visible only when the tube is tilted carefully.

Quality Checks

Pre-Test Quality Assurance

• Verify that the plasma is within its expiration date and has been stored at 2–8°C.
• Confirm that the incubator temperature is stable at 35–37°C.
• Ensure that the bacterial culture is pure and not contaminated. Perform a Gram stain to confirm staphylococcal morphology (Gram-positive cocci in clusters).

During the Test

• For the slide test, use a fresh loop for each suspension to avoid cross-contamination.
• For the tube test, use sterile technique when inoculating the plasma.
• Record the exact time of inoculation and each observation time.

Post-Test Verification

• If the tube test is negative at 4 hours, re-examine at 24 hours before reporting as negative. Some strains produce coagulase slowly.
• If the slide test is positive but the tube test is negative, consider the possibility of a false-positive slide test (e.g., due to autoagglutination or protein A). Repeat both tests with a fresh culture.
• If the slide test is negative but the tube test is positive, the organism is coagulase-positive (free coagulase only). This is rare but can occur with some S. aureus strains.

Result Interpretation

Slide Coagulase Test

Tube Coagulase Test

Combined Interpretation

• Slide positive, tube positive: S. aureus (most common pattern).
• Slide negative, tube positive: S. aureus (rare; may be due to weak clumping factor).
• Slide positive, tube negative: Possible false-positive slide test; repeat both tests. If consistent, consider other coagulase-positive staphylococci (e.g., S. intermedius group).
• Slide negative, tube negative: Coagulase-negative staphylococcus (CoNS).

Troubleshooting

Limitations

Slide Coagulase Test Limitations

• False positives: Some strains of S. aureus produce protein A, which can bind to the Fc region of IgG and cause clumping. Additionally, rough or mucoid colonies may autoagglutinate in saline.
• False negatives: Strains with weak clumping factor, or those that are heavily encapsulated, may not clump visibly.
• Not suitable for all staphylococci: The slide test is optimized for S. aureus and may not reliably detect coagulase in other species (e.g., S. intermedius, S. hyicus).

Tube Coagulase Test Limitations

• Time-consuming: Requires up to 24 hours for a definitive negative result.
• Plasma variability: Different batches of rabbit plasma may have varying reactivity. Always use a positive control.
• Citrate interference: If citrate is used as an anticoagulant in the plasma, some bacteria can utilize citrate, leading to a false-negative result. Use EDTA or heparinized plasma if available.
• Proteolytic strains: Some bacteria produce proteases that can dissolve a clot, leading to a false-negative reading if the tube is examined too late.

General Limitations

• Not a standalone identification: The coagulase test should be used in conjunction with other tests (e.g., catalase, DNase, mannitol fermentation, Gram stain) for definitive identification.
• Species variation: While S. aureus is the most common coagulase-positive staphylococcus, other species such as S. intermedius, S. hyicus, and S. delphini can also be coagulase-positive. These are less common in human clinical specimens but may be encountered in veterinary samples.
• Mixed cultures: The test requires a pure culture. If the original sample contains multiple organisms, the result may be misleading.

Documentation

Proper documentation is essential for reproducibility and quality assurance in any laboratory setting. For the coagulase test, record the following information:

Essential Data Points

• Sample identification: Unique identifier for the bacterial isolate (e.g., lab number, patient ID, or source).
• Date and time: When the test was performed and when results were read.
• Test type: Slide or tube coagulase test.
• Plasma source: Commercial kit name, lot number, and expiration date.
• Controls: Results of positive, negative, and autoagglutination controls.
• Observation times: For the tube test, record results at 1, 2, 4, and 24 hours.
• Result: Positive, negative, or invalid (with reason).
• Technician initials: Who performed the test.

Example Documentation Entry

Sample: Isolate #45 (from wound swab)
Date: 2025-03-15
Test: Tube coagulase test
Plasma: Rabbit plasma (Kit XYZ, Lot #12345, Exp: 2025-06)
Controls:
  - Positive (S. aureus ATCC 25923): Clot at 2 hours
  - Negative (S. epidermidis ATCC 12228): No clot at 24 hours
  - Plasma control: No clot at 24 hours
Results:
  - 1 hour: No clot
  - 2 hours: Small clot visible
  - 4 hours: Firm clot
  - 24 hours: Firm clot (confirmed)
Interpretation: Coagulase-positive (S. aureus)
Technician: J. Smith

Reporting

• Report the result as "Coagulase-positive" or "Coagulase-negative" along with the method used.
• If the slide test is positive, note that it is a presumptive result and recommend confirmation by tube test.
• For research purposes, include the strain designation and any relevant phenotypic characteristics.

Biosafety Considerations

The coagulase test is typically performed with pure cultures of staphylococci, which are classified as Biosafety Level 2 (BSL-2) organisms in clinical settings due to their potential pathogenicity. However, in teaching laboratories using well-characterized, non-pathogenic strains (e.g., S. aureus ATCC 25923 and S. epidermidis ATCC 12228), the test can be safely performed at BSL-1 with standard microbiological practices [5].

BSL-1 Routine Practices

• Hand hygiene: Wash hands before and after handling cultures.
• Personal protective equipment (PPE): Wear a lab coat and gloves. Safety glasses are recommended when working with liquid cultures.
• Work surface: Use a disinfected, non-porous work surface. Clean with 10% bleach or 70% ethanol before and after use.
• Waste disposal: Dispose of contaminated materials (slides, tubes, loops) in biohazard waste containers. Autoclave all waste before disposal.
• Spill management: Cover spills with absorbent material, apply disinfectant, and allow contact time before cleanup.

Additional Precautions for Clinical Isolates

• If working with clinical isolates of unknown pathogenicity, treat all cultures as BSL-2.
• Perform all manipulations in a biological safety cabinet (BSC) if aerosol-generating procedures (e.g., vortexing, pipetting) are involved.
• Never mouth-pipette. Use mechanical pipetting devices.
• Label all cultures clearly with biohazard symbols.

Decontamination

• Autoclave all used plasma tubes, slides, and loops at 121°C for 30 minutes.
• Disinfect work surfaces with an appropriate disinfectant (e.g., 10% bleach, 70% ethanol, or a quaternary ammonium compound) after each session.

For more detailed biosafety guidelines, refer to the CDC/NIH publication Biosafety in Microbiological and Biomedical Laboratories (BMBL), 6th Edition [5].

Frequently Asked Questions

1. Can I use human plasma instead of rabbit plasma for the coagulase test?

Human plasma can be used but is not recommended for routine testing. Rabbit plasma is preferred because it provides more consistent results and lacks inhibitors that may interfere with the reaction. Human plasma may contain variable levels of coagulase-reacting factor and antibodies that can inhibit clot formation, leading to false-negative results. If human plasma must be used, it should be tested with positive and negative controls in parallel.

2. Why does my slide coagulase test show clumping in the saline control?

Clumping in the saline control indicates autoagglutination, which means the bacterial cells are clumping spontaneously without the addition of plasma. This can occur with rough colony variants, mucoid strains, or certain species that have sticky surface components. When autoagglutination is observed, the slide test is invalid, and you must use the tube coagulase test for accurate results.

3. How long should I incubate the tube coagulase test before reporting a negative result?

The tube coagulase test should be examined at 1, 2, 4, and 24 hours. Most positive reactions occur within 4 hours, but some strains (especially those that are slow coagulase producers) may only show a clot at 24 hours. Therefore, a negative result should not be reported until the 24-hour reading is complete. If a clot appears only at 24 hours, repeat the test with a fresh 18-hour culture to confirm.

4. Can the coagulase test differentiate Staphylococcus aureus from other coagulase-positive staphylococci?

The coagulase test alone cannot differentiate S. aureus from other coagulase-positive staphylococci such as S. intermedius, S. hyicus, or S. delphini. These species are less common in human clinical specimens but may be encountered in veterinary samples. Additional tests, such as mannitol fermentation, DNase production, or molecular methods (e.g., PCR targeting the nuc gene), are needed for definitive species identification.

References and Further Reading

1. Smartphone-based multispectral autofluorescence analysis of bacteria mixtures of staphylococci using convolutional neural network. Reynolds J, Sosnowski K, Carlson C, et al. (2026). PubMed ID: 41578371. Describes the clinical importance of distinguishing S. aureus from CoNS using advanced analytical methods. Link

2. Prevalence, antimicrobial resistance, and public health risk assessment of zoonotic bacterial pathogens in raw cattle meat. Reda M, Mebrahtu T, Gebru M, et al. (2025). PubMed ID: 41204200. Highlights the prevalence of S. aureus in food samples and the need for reliable identification methods. Link

3. Colonization of selected antibiotic-resistant bacteria among pregnant women. Shamil Mafras FS, Francis VR, Kudagammana W, et al. (2026). PubMed ID: 41692738. Demonstrates the use of routine microbiological methods, including coagulase testing, for MRSA surveillance. Link

4. Characteristics of the Mare-Uterine-Culture-Based Bacterial Composition Using Practical Clinical Evaluation Methods. Carvalho IB, Branco S, Laranjo M, et al. (2025). PubMed ID: 40333165. Illustrates the application of standard microbiological methods in veterinary settings. Link

5. Biosafety in Microbiological and Biomedical Laboratories (BMBL), 6th Edition. CDC and NIH. U.S. Department of Health and Human Services (2020). Authoritative guidelines for laboratory biosafety practices. Link

6. NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules. National Institutes of Health. Provides biosafety framework for research laboratories. Link

7. NCBI Bookshelf: Molecular Biology and Laboratory Methods. National Center for Biotechnology Information. Searchable collection of authoritative biomedical methods references. Link

Related Articles

• How to Perform a Urease Test: Principle, Procedure, and Interpretation
• How to Perform a Methyl Red and Voges-Proskauer (MR-VP) Test
• How to Perform a Catalase Test: Principle, Procedure, and Interpretation
• How to Perform an Oxidase Test: Principle, Procedure, and Interpretation
• How to Perform an Indole Test: Principle, Procedure, and Interpretation
• How to Perform a Citrate Utilization Test: Simmons Citrate Agar Protocol